✦ LIBER ✦

Paclitaxel, ifosfamide, and nedaplatin (TIN) salvage chemotherapy for patients with advanced germ cell tumors

✍ Scribed by Norio Nonomura; Daizo Oka; Kazuo Nishimura; Masashi Nakayama; Hitoshi Inoue; Yoichi Mizutani; Tsuneharu Miki; Akihiko Okuyama

Book ID: 108977337
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 78 KB
Volume: 14
Category: Article
ISSN: 0919-8172
DOI: 10.1111/j.1442-2042.2006.01702.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MP-21.08: Salvage chemotherapy with pacl

MP-21.08: Salvage chemotherapy with paclitaxel, gemcitabine and nedaplatin (TGN) for cisplatin refractory germ cell tumors

✍ T. Nakamura; K. Mikami; N. Takaha; T. Shiraishi; A. Kawauchi; Y. Mizutani; T. Mi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 83 KB

910 Ifosfamide-based salvage chemotherap

910 Ifosfamide-based salvage chemotherapy for patients with resistant germ cell tumors—our experiences

✍ D. Donat; J. Srojkov; A. Živanović; J. Djozić; L.J. Miljković; A. Donat; N. Budi 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Salvage chemotherapy with paclitaxel and

Salvage chemotherapy with paclitaxel and gemcitabine plus nedaplatin (TGN) as part of multidisciplinary therapy in patients with heavily pretreated cisplatin-refractory germ cell tumors

✍ Takumi Shiraishi; Terukazu Nakamura; Kazuya Mikami; Natsuki Takaha; Akihiro Kawa 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 236 KB

Salvage therapy with paclitaxel, ifosfam

Salvage therapy with paclitaxel, ifosfamide and cisplatin is effective in patients with relapsed advanced testicular germ cell cancer

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Salvage chemotherapy with paclitaxel, if

Salvage chemotherapy with paclitaxel, ifosfamide, and nedaplatin in patients with urothelial cancer who had received prior cisplatin-based therapy

✍ Nobuo Shinohara; Toru Harabayashi; Shin Suzuki; Kazuhiro Nagao; Haruo Seki; Masa 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 214 KB

The role of ifosfamide plus cisplatin-ba

The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors

✍ Robert J. Motzer; Karen Cooper; Nancy L. Geller; Dean F. Bajorin; Ethan Dmitrovs 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 537 KB

A prospective study of four cycles of etoposide with ifosfamide and cisplatin (VIP) chemotherapy was conducted in 42 germ cell tumor (GCT) patients who were refractory to cisplatin with etoposide/vinblastine-based therapy. Forty patients were evaluable for response. Ten patients (25%) had a complete